Exposure-response relationships for everolimus in de novo kidney transplantation: defining a therapeutic range-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Exposure-response relationships for everolimus in de novo kidney transplantation: defining a therapeutic range

Published:2002-03 Issue:6 Volume:73 Page:920-925
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:Transplantation

Author:

Kovarik John M.,Kaplan Bruce,Tedesco Silva Helio,Kahan Barry D.,Dantal Jacque,Vitko Stefan,Boger Robert,Rordorf Christiane

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference13 articles.

1. SDZ RAD, A NEW RAPAMYCIN DERIVATIVE

2. Rapamune (Sirolimus, Rapamycin): An Overview and Mechanism of Action

3. A PHASE I STUDY OF A 4-WEEK COURSE OF SDZ-RAD (RAD) IN QUIESCENT CYCLOSPORINE-PREDNISONE-TREATED RENAL TRANSPLANT RECIPIENTS1,2

4. RAD IN DE NOVO RENAL TRANSPLANTATION: COMPARISON OF THREE DOSES ON THE INCIDENCE AND SEVERITY OF ACUTE REJECTION 1

5. Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study

Cited by 125 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Model-informed precision dosing: State of the art and future perspectives;Advanced Drug Delivery Reviews;2024-08

2. Therapeutic drug monitoring in kidney and liver transplantation: current advances and future directions;Expert Review of Clinical Pharmacology;2024-05-16

3. Drug-Induced Myelosuppression in Kidney Transplant Patients;Experimental and Clinical Transplantation;2021-10

4. Interferon‐γ‐induced HLA Class II expression on endothelial cells is decreased by inhibition of mTOR and HMG‐CoA reductase;FEBS Open Bio;2020-04-15

5. Target of rapamycin inhibitors (TOR-I; sirolimus and everolimus) for primary immunosuppression in kidney transplant recipients;Cochrane Database of Systematic Reviews;2019-12-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3